Payment Breakdown by Category
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Consulting Fee | $1,320 | 2 | 93.4% |
| Food and Beverage | $93.05 | 5 | 6.6% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Fresenius Kabi USA, LLC | $1,200 | 1 | $0 (2023) |
| Vifor (International) Ltd. | $120.00 | 1 | $0 (2020) |
| Celgene Corporation | $65.41 | 3 | $0 (2017) |
| AbbVie, Inc. | $27.64 | 2 | $0 (2017) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2023 | $1,200 | 1 | Fresenius Kabi USA, LLC ($1,200) |
| 2020 | $120.00 | 1 | Vifor (International) Ltd. ($120.00) |
| 2017 | $93.05 | 5 | Celgene Corporation ($65.41) |
All Payment Transactions
7 individual payment records from CMS Open Payments
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 02/21/2023 | Fresenius Kabi USA, LLC | — | Consulting Fee | Cash or cash equivalent | $1,200.00 | General |
| 02/07/2020 | Vifor (International) Ltd. | — | Consulting Fee | Cash or cash equivalent | $120.00 | General |
| 05/12/2017 | AbbVie, Inc. | Humira (Biological) | Food and Beverage | In-kind items and services | $12.87 | General |
| Category: Immunology | ||||||
| 02/22/2017 | AbbVie, Inc. | Humira (Biological) | Food and Beverage | In-kind items and services | $14.77 | General |
| Category: Immunology | ||||||
| 01/26/2017 | Celgene Corporation | Otezla (Drug) | Food and Beverage | In-kind items and services | $24.50 | General |
| Category: Dermatology | ||||||
| 01/20/2017 | Celgene Corporation | Otezla (Drug) | Food and Beverage | In-kind items and services | $20.92 | General |
| Category: Dermatology | ||||||
| 01/13/2017 | Celgene Corporation | Otezla (Drug) | Food and Beverage | In-kind items and services | $19.99 | General |
| Category: Dermatology | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 3 | 160 | 259 | $89,144 | $20,179 |
| 2022 | 6 | 209 | 307 | $114,272 | $26,573 |
| 2021 | 5 | 187 | 253 | $85,827 | $20,613 |
| 2020 | 5 | 222 | 285 | $74,269 | $17,022 |
All Medicare Procedures & Services
28 procedure records from CMS Medicare Utilization — Page 1 of 2
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 57 | 101 | $32,926 | $7,283 | 22.1% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Facility | 2023 | 52 | 84 | $27,384 | $6,560 | 24.0% |
| 99215 | Established patient office or other outpatient visit, 40-54 minutes | Office | 2023 | 29 | 48 | $23,088 | $5,273 | 22.8% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Facility | 2023 | 11 | 13 | $2,873 | $615.23 | 21.4% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 11 | 13 | $2,873 | $447.44 | 15.6% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 56 | 95 | $30,970 | $6,370 | 20.6% |
| 99215 | Established patient office or other outpatient visit, 40-54 minutes | Office | 2022 | 26 | 41 | $19,721 | $5,131 | 26.0% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Facility | 2022 | 42 | 64 | $20,864 | $4,789 | 23.0% |
| 99215 | Established patient office or other outpatient visit, 40-54 minutes | Facility | 2022 | 25 | 40 | $19,240 | $4,623 | 24.0% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2022 | 15 | 15 | $6,690 | $1,631 | 24.4% |
| 99222 | Initial hospital inpatient care per day, typically 50 minutes | Facility | 2022 | 12 | 12 | $5,292 | $1,384 | 26.2% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Facility | 2022 | 11 | 11 | $4,906 | $1,047 | 21.3% |
| 99232 | Follow-up hospital inpatient care per day, typically 25 minutes | Facility | 2022 | 11 | 15 | $3,495 | $915.93 | 26.2% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2022 | 11 | 14 | $3,094 | $682.44 | 22.1% |
| 99214 | Established patient outpatient visit, total time 30-39 minutes | Facility | 2021 | 63 | 94 | $30,314 | $7,258 | 23.9% |
| 99214 | Established patient outpatient visit, total time 30-39 minutes | Office | 2021 | 50 | 75 | $24,384 | $5,603 | 23.0% |
| 99215 | Established patient outpatient visit, total time 40-54 minutes | Facility | 2021 | 14 | 21 | $9,988 | $2,439 | 24.4% |
| 99204 | New patient outpatient visit, total time 45-59 minutes | Office | 2021 | 18 | 18 | $8,028 | $2,138 | 26.6% |
| 99204 | New patient outpatient visit, total time 45-59 minutes | Facility | 2021 | 11 | 11 | $4,906 | $1,324 | 27.0% |
| 99213 | Established patient outpatient visit, total time 20-29 minutes | Facility | 2021 | 16 | 19 | $4,199 | $954.56 | 22.7% |
| 99443 | Physician telephone patient service, 21-30 minutes of medical discussion | Facility | 2021 | 15 | 15 | $4,008 | $896.64 | 22.4% |
| 99443 | Physician telephone patient service, 21-30 minutes of medical discussion | Facility | 2020 | 69 | 89 | $23,621 | $5,820 | 24.6% |
| 99214 | Established patient office or other outpatient, visit typically 25 minutes | Facility | 2020 | 70 | 94 | $24,440 | $5,119 | 20.9% |
| 99214 | Established patient office or other outpatient, visit typically 25 minutes | Office | 2020 | 35 | 50 | $13,000 | $3,210 | 24.7% |
| 99204 | New patient office or other outpatient visit, typically 45 minutes | Facility | 2020 | 12 | 12 | $5,124 | $1,129 | 22.0% |
About Dr. Mark Robbins, MD
Dr. Mark Robbins, MD is a Rheumatology healthcare provider based in Boston, Massachusetts. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 12/14/2006. The National Provider Identifier (NPI) number assigned to this provider is 1609938869.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Mark Robbins, MD has received a total of $1,413 in payments from pharmaceutical and medical device companies, with $1,200 received in 2023. These payments were reported across 7 transactions from 4 companies. The most common payment nature is "Consulting Fee" ($1,320).
As a Medicare-enrolled provider, Robbins has provided services to 778 Medicare beneficiaries, totaling 1,104 services with total Medicare billing of $84,387. Data is available for 4 years (2020–2023), covering 28 distinct procedure/service records.
Practice Information
- Specialty Rheumatology
- Location Boston, MA
- Active Since 12/14/2006
- Last Updated 07/10/2018
- Taxonomy Code 207RR0500X
- Entity Type Individual
- NPI Number 1609938869
Products in Payments
- Otezla (Drug) $65.41
- Humira (Biological) $27.64
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Rheumatology Doctors in Boston
Lee Simon, M.d, M.D
Rheumatology — Payments: $917,853
Michael Weinblatt, Md, MD
Rheumatology — Payments: $408,548
Sebastian Unizony, Md, MD
Rheumatology — Payments: $172,168
Jack Bukowski, Md Phd, MD PHD
Rheumatology — Payments: $153,965
Michael Brenner, Md, MD
Rheumatology — Payments: $141,423
Dr. Joerg Ermann, Md, MD
Rheumatology — Payments: $131,409